NasdaqCM - Nasdaq Real Time Price USD

MoonLake Immunotherapeutics (MLTX)

37.62
-0.04
(-0.11%)
At close: May 16 at 4:00:00 PM EDT
37.62
0.00
(0.00%)
After hours: May 16 at 4:05:08 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
Total Revenue
0
0
0
0
Operating Expense
170,756.08
143,091.08
54,123.10
65,061.42
Operating Income
-170,756.08
-143,091.08
-54,123.10
-65,061.42
Other Income Expense
23,310.88
22,128.88
10,138.37
591.73
Pretax Income
-147,463.20
-120,962.20
-43,984.73
-64,469.69
Tax Provision
365.20
282.20
94.39
36.37
Net Income Common Stockholders
-145,206.52
-118,935.52
-36,007.26
-49,973.25
Diluted NI Available to Com Stockholders
-145,206.52
-118,935.52
-36,007.26
-49,973.25
Basic EPS
-2.30
-1.89
-0.73
-1.28
Diluted EPS
-2.30
-1.89
-0.73
-1.28
Basic Average Shares
63,019.38
62,870.24
49,122.53
38,977.60
Diluted Average Shares
63,019.38
62,870.24
49,122.53
38,977.60
Total Operating Income as Reported
-170,756.08
-143,091.08
-54,123.10
-65,061.42
Total Expenses
170,756.08
143,091.08
54,123.10
65,061.42
Net Income from Continuing & Discontinued Operation
-145,206.52
-118,935.52
-36,007.26
-49,973.25
Normalized Income
-145,206.52
-118,935.52
-36,007.26
-49,973.25
EBIT
-169,574.08
-143,091.08
-54,123.10
-65,061.42
EBITDA
-168,139.35
-141,706.35
-53,752.78
-64,896.63
Reconciled Depreciation
1,434.73
1,384.73
370.32
164.78
Net Income from Continuing Operation Net Minority Interest
-145,206.52
-118,935.52
-36,007.26
-49,973.25
Normalized EBITDA
-168,139.35
-141,706.35
-53,752.78
-64,896.63
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
12/31/2022 - 10/20/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PTGX Protagonist Therapeutics, Inc.
44.49
+0.18%
 
APGE Apogee Therapeutics, Inc.
40.62
-0.05%
 
RVMD Revolution Medicines, Inc.
39.54
+0.25%
 
MRUS Merus N.V.
41.56
+3.69%
 
EWTX Edgewise Therapeutics, Inc.
14.78
+2.28%
 
SRRK Scholar Rock Holding Corporation
30.55
-0.91%
 
AKRO Akero Therapeutics, Inc.
38.87
-2.73%
 
CYTK Cytokinetics, Incorporated
31.00
+3.89%
 
SLNO Soleno Therapeutics, Inc.
75.01
-0.08%
 
VRDN Viridian Therapeutics, Inc.
12.94
+2.54%